NDUFS4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.539400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.188600E-01
Normal-vs-Stage2
5.408000E-01
Normal-vs-Stage3
7.283200E-01
Normal-vs-Stage4
3.924400E-01
Stage1-vs-Stage2
8.312600E-01
Stage1-vs-Stage3
9.772400E-01
Stage1-vs-Stage4
8.083000E-01
Stage2-vs-Stage3
9.137600E-01
Stage2-vs-Stage4
7.222200E-01
Stage3-vs-Stage4
9.589600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.302800E-01
Normal-vs-AfricanAmerican
6.399000E-01
Normal-vs-Asian
9.519200E-01
Caucasian-vs-AfricanAmerican
6.244600E-01
Caucasian-vs-Asian
1.105030E-01
AfricanAmerican-vs-Asian
5.139600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.443200E-01
Normal-vs-Female
4.825000E-01
Male-vs-Female
6.545000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.394800E-01
Normal-vs-Age(41-60Yrs)
2.274600E-01
Normal-vs-Age(61-80Yrs)
6.242600E-01
Normal-vs-Age(81-100Yrs)
9.382500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.842620E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.689000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.839600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.413900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.878200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.434100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.824400E-01
Normal-vs-Daily Drinker
4.462800E-01
Normal-vs-Weekly Drinker
8.839200E-01
Normal-vs-Occasional Drinker
2.220600E-01
Normal-vs-Social Drinker
3.193000E-01
Non Drinker-vs-Daily Drinker
4.235200E-01
Non Drinker-vs-Weekly Drinker
2.940600E-01
Non Drinker-vs-Occasional Drinker
7.423800E-02
Non Drinker-vs-Social Drinker
3.560600E-01
Daily Drinker-vs-Weekly Drinker
9.768100E-02
Daily Drinker-vs-Occasional Drinker
3.208000E-01
Daily Drinker-vs-Social Drinker
8.769200E-01
Weekly Drinker-vs-Occasional Drinker
1.584280E-02
Weekly Drinker-vs-Social Drinker
6.159700E-02
Occasional Drinker-vs-Social Drinker
4.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.019430E-01
Normal-vs-Grade 2
1.290160E-02
Normal-vs-Grade 3
1.846010E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.613400E-01
Grade 1-vs-Grade 3
8.462800E-01
Grade 1-vs-Grade 4
1.019430E-01
Grade 2-vs-Grade 3
6.822800E-01
Grade 2-vs-Grade 4
1.290160E-02
Grade 3-vs-Grade 4
1.846010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.574600E-01
Normal-vs-NonDiabetic
4.518600E-01
Diabetic-vs-NonDiabetic
6.229600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.407200E-01
Normal-vs-NoPancreatitis
4.861800E-01
Pancreatitis-vs-NoPancreatitis
4.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.466220E-01
Normal-vs-N1
6.185000E-01
N0-vs-N1
2.120000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.727400E-01
Normal-vs-TP53-NonMutant
4.292200E-01
TP53-Mutant-vs-TP53-NonMutant
6.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
